Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Pulmonary Sarcoidosis
NCT04020380Phase 2Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Sep 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azithromycin in pulmonary sarcoidosis, sponsored by Hull University Teaching Hospitals. Primary endpoint: Change in 24 hour cough counts at 3 months. Started Sep 2019; status: completed.
02
Drugs
azithromycin
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT04020380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020380.